cyclohexanol has been researched along with Mood Disorders in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miller, MC | 1 |
| Chugunov, AV; Gulieva, AE; Kamchatnov, PR; Kunel'skaia, NL; Umarova, KhIa | 1 |
| Hardy-Baylé, MC; Passerieux, C | 1 |
| Abrams, M; Cook, IA; Hunter, AM; Leuchter, AF | 1 |
| Coplan, JD; Dwork, AJ; Fenton, AA; Fonseka, J; Glennon, E; Insanally, M; Park, S; Perera, TD; Persky, M; Sackeim, HA; Thirumangalakudi, L | 1 |
| Bowers, L; Callaghan, P; Clark, N; Evers, C | 1 |
| Bourgeois, JA; Brunberg, JA; Farzin, F; Hagerman, P; Hagerman, R; Hessl, D; Tassone, F; Zhang, L | 1 |
| Chen, MC; Lane, HY; Lin, CH; Lin, CY; Lin, KS | 1 |
| Brilmyer, M; Kant, R; Zeiler, D; Zimmer, B | 1 |
1 review(s) available for cyclohexanol and Mood Disorders
| Article | Year |
|---|---|
[Mood disorders].
Topics: Adolescent; Adult; Age Factors; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Diagnosis, Differential; Drug Therapy, Combination; Electroconvulsive Therapy; Female; Hospitalization; Humans; Male; Mood Disorders; Personality Disorders; Pregnancy; Prognosis; Psychotherapy; Psychotropic Drugs; Recurrence; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Suicide; Time Factors; Venlafaxine Hydrochloride; Young Adult | 2008 |
2 trial(s) available for cyclohexanol and Mood Disorders
| Article | Year |
|---|---|
Brain functional changes (QEEG cordance) and worsening suicidal ideation and mood symptoms during antidepressant treatment.
Topics: Adult; Analysis of Variance; Antidepressive Agents; Antidepressive Agents, Second-Generation; Brain; California; Causality; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Electroencephalography; Female; Fluoxetine; Humans; Male; Mood Disorders; Psychiatric Status Rating Scales; Severity of Illness Index; Suicide; Venlafaxine Hydrochloride | 2010 |
Role of hippocampal neurogenesis in mnemonic segregation: implications for human mood disorders.
Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Cyclohexanols; Hippocampus; Male; Memory; Mood Disorders; Neurogenesis; Neurons; Placebos; Psychomotor Performance; Rats; Rats, Long-Evans; Stress, Psychological; Venlafaxine Hydrochloride | 2013 |
6 other study(ies) available for cyclohexanol and Mood Disorders
| Article | Year |
|---|---|
When depression doesn't lead with depression.
Topics: Anger; Bipolar Disorder; Cyclohexanols; Depression; Depressive Disorder, Major; Emotions; Female; Fluoxetine; Humans; Irritable Mood; Male; Mood Disorders; Prefrontal Cortex; Venlafaxine Hydrochloride | 2013 |
[Correction of affective disorders in patients with cochlear-vestibular disturbances of vascular origin].
Topics: Adult; Aged; Analgesics; Antidepressive Agents, Second-Generation; Audiometry; Cochlear Diseases; Cyclohexanols; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mood Disorders; Psychometrics; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome; Ultrasonography, Doppler, Transcranial; Venlafaxine Hydrochloride; Vestibular Diseases | 2008 |
Comparisons of psychotropic drug prescribing patterns in acute psychiatric wards across Europe.
Topics: Adult; Benzodiazepines; Biperiden; Chlorpromazine; Clozapine; Cyclohexanols; Diazepam; Drug Administration Schedule; Drug Prescriptions; Drug Therapy, Combination; Drug Utilization Review; Europe; Female; Humans; Male; Mood Disorders; Olanzapine; Pharmacoepidemiology; Practice Patterns, Physicians'; Psychiatric Department, Hospital; Psychotropic Drugs; Schizophrenia; Time Factors; Venlafaxine Hydrochloride | 2004 |
Dementia with mood symptoms in a fragile X premutation carrier with the fragile X-associated tremor/ataxia syndrome: clinical intervention with donepezil and venlafaxine.
Topics: Aged; Antidepressive Agents, Second-Generation; Ataxia; Atrophy; Brain; Cyclohexanols; Dementia; Dominance, Cerebral; Donepezil; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fragile X Mental Retardation Protein; Fragile X Syndrome; Genetic Carrier Screening; Humans; Image Processing, Computer-Assisted; Indans; Magnetic Resonance Imaging; Male; Mental Status Schedule; Mood Disorders; Neurologic Examination; Neuropsychological Tests; Nootropic Agents; Piperidines; Tremor; Trinucleotide Repeats; Venlafaxine Hydrochloride | 2006 |
Time to rehospitalization in patients with major depressive disorder taking venlafaxine or fluoxetine.
Topics: Adult; Combined Modality Therapy; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Female; Fluoxetine; Hospitalization; Humans; Interview, Psychological; Male; Mood Disorders; Patient Readmission; Prevalence; Selective Serotonin Reuptake Inhibitors; Surveys and Questionnaires; Time Factors; Tobacco Use Disorder; Venlafaxine Hydrochloride | 2008 |
Antidepressant efficacy and cardiovascular safety of venlafaxine in young vs old patients with comorbid medical disorders.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Blood Pressure; Cardiovascular Diseases; Cerebrovascular Disorders; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Mood Disorders; Risk Factors; Venlafaxine Hydrochloride | 1997 |